Valuation: Edwards Lifesciences Corporation

Capitalization 43.31B 37.57B 35.39B 32.15B 59.48B 3,751B 67.02B 419B 160B 1,718B 163B 159B 6,317B P/E ratio 2025 *
30.5x
P/E ratio 2026 * 27.4x
Enterprise value 39.94B 34.65B 32.63B 29.65B 54.86B 3,459B 61.81B 386B 148B 1,585B 150B 147B 5,826B EV / Sales 2025 *
6.78x
EV / Sales 2026 * 6.04x
Free-Float
89.32%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.20%
1 week-1.76%
Current month-5.61%
1 month-1.28%
3 months+4.78%
6 months-1.31%
Current year-0.27%
More quotes
1 week 72.42
Extreme 72.4219
74.75
1 month 72.42
Extreme 72.4219
78.75
Current year 65.94
Extreme 65.94
78.75
1 year 58.93
Extreme 58.93
95.25
3 years 58.93
Extreme 58.93
107.92
5 years 58.93
Extreme 58.93
131.73
10 years 20.84
Extreme 20.8433
131.73
More quotes
Manager TitleAgeSince
Chief Executive Officer 57 2023-05-10
Director of Finance/CFO 58 2013-12-31
Chief Tech/Sci/R&D Officer - 2019-01-31
Director TitleAgeSince
Chairman 68 2024-05-06
Director/Board Member 61 2015-02-09
Director/Board Member 57 2023-05-10
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-0.20%-1.76%-18.78%-18.68% 43.31B
-0.03%-0.55%+17.75%+153.89% 183B
+1.36%-1.21%-29.53%-23.37% 150B
-0.07%+1.56%+30.36%+173.56% 150B
+1.00%-2.13%-22.97%-20.14% 141B
+0.72%+1.27%-12.81%+3.89% 59.43B
+0.58%-4.22%-21.90%-27.19% 38.29B
+1.12%+1.74%+23.25%+24.98% 37.13B
+0.03%-1.30%-13.28%+1.55% 32.83B
-0.85%-1.34%-9.97% - 32.64B
Average +0.37%-0.77%-5.79%+29.83% 86.68B
Weighted average by Cap. +0.46%-0.60%-2.52%+56.50%
See all sector performances

Financials

2025 *2026 *
Net sales 5.89B 5.11B 4.81B 4.37B 8.09B 510B 9.12B 57.01B 21.82B 234B 22.11B 21.64B 859B 6.45B 5.6B 5.27B 4.79B 8.86B 559B 9.99B 62.45B 23.9B 256B 24.22B 23.7B 941B
Net income 1.42B 1.23B 1.16B 1.06B 1.95B 123B 2.2B 13.76B 5.27B 56.44B 5.34B 5.22B 207B 1.58B 1.37B 1.29B 1.17B 2.17B 137B 2.44B 15.28B 5.85B 62.68B 5.93B 5.8B 230B
Net Debt -3.37B -2.92B -2.75B -2.5B -4.62B -292B -5.21B -32.58B -12.47B -134B -12.63B -12.36B -491B -4.31B -3.74B -3.52B -3.2B -5.92B -373B -6.67B -41.7B -15.96B -171B -16.17B -15.83B -629B
More financial data * Estimated data
Logo Edwards Lifesciences Corporation
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - heart valves and surgery products (75.5%); - hemodynamic monitoring systems (6.5%); - other (18%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.9%), Europe (24.3%), Japan (6.3%) and others (10.5%).
Employees
15,800
More about the company
Date Price Change Volume
25-06-20 73.83 $ -0.20% 7,031,046
25-06-18 73.98 $ +0.97% 3,983,296
25-06-17 73.27 $ -2.07% 3,013,112
25-06-16 74.82 $ -0.44% 2,925,588

Delayed Quote Nyse, June 20, 2025 at 04:00 pm

More quotes
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
73.83USD
Average target price
81.01USD
Spread / Average Target
+9.72%
Consensus

Quarterly revenue - Rate of surprise